Evidence map›Paper›PMID 35404239›Full record

ArticleTurkish thoracic journal2022

Six-Week Hospital-Based Pulmonary Rehabilitation in Covid Pneumonia ICU Survivors: Experience from a Tertiary Care Center in Central India.

Alkesh Kumar Khurana, Aqeel Hussain, Abhishek Goyal, Sunaina Tejpal Karna, Saurabh Saigal, Raj Krishnan Soman, Mamta Verma, Sagar Khadanga, Gaurav Sahu, Brijendra Singh

Open access · greenAbstract read
In one paragraph

Article in Turkish thoracic journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. The heart and SARS-CoV-2.Medicina clinica · 2022
    Review
  4. The heart and SARS-CoV-2.Medicina clinica (English ed.) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Alkesh Kumar KhuranaDepartment of Pulmonary Medicine, AIIMS, Bhopal, Madhya Pradesh, India.
Aqeel HussainDepartment of Pulmonary Medicine, AIIMS, Bhopal, Madhya Pradesh, India.
Abhishek GoyalDepartment of Pulmonary Medicine, AIIMS, Bhopal, Madhya Pradesh, India.
Sunaina Tejpal KarnaAnesthesia and Critical Care, AIIMS, Bhopal, Madhya Pradesh, India.
Saurabh SaigalAnesthesia and Critical Care, AIIMS, Bhopal, Madhya Pradesh, India.
Raj Krishnan SomanDepartment of Pulmonary Medicine, AIIMS, Bhopal, Madhya Pradesh, India.
Mamta VermaDepartment of Nursing, AIIMS, Bhopal, Madhya Pradesh, India.
Sagar KhadangaDeparment of General Medicine, AIIMS, Bhopal, Madhya Pradesh, India.
Gaurav SahuDepartment of Pulmonary Medicine, AIIMS, Bhopal, Madhya Pradesh, India.
Brijendra SinghDepartment of Physical Medicine and Rehabilitation, AIIMS, Bhopal, Madhya Pradesh, India.
All India Institute of Medical Sciences Bhopal · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThere is very limited data on the usefulness of pulmonary rehabilitation in patients with coronavirus pneumonia who have survived intensive care unit care. The primary aim was to explore the feasibility of conducting a pulmonary rehabilitation program in patients with coronavirus disease-19 pneumonia surviving intensive care. The secondary aim was to study the impact of a hospital-based 6-week pulmonary rehabilitation program on exercise capacity, quality of life, and psychological parameters in these patients. This study was conducted at the Center for Pulmonary Rehabilitation, Department of Pulmonary Medicine of the institute. MATERIAL AND

methodsA total of 27 patients were enrolled. Among them, 14 patients who completed the desired 12 sessions over 6 weeks constituted the pulmonary rehabilitation group and 13 patients who either did not consent or defaulted within the first 2 weeks were considered as controls. Both groups had assessments at 0 and 6 weeks that included a 6-Minute Walk Test, Incremental Shuttle Walk Test, mMRC Dyspnea Scale, Baseline Dyspnea Index, and Transitional Dyspnea Index, Saint George's Respiratory Questionnaire score, and Depression, Anxiety, Stress Scale-21 score.

resultsSignificant improvement in dyspnea by mMRC (P = .01) and exercise capacity as measured by 6-Minute Walk Test (P <.001) and Incremental Shuttle Walk Test (P = .025) was seen in the pulmonary rehabilitation group as compared to the control group. There was no significant improvement in quality of life and psychological parameters (Depression, Anxiety, Stress Scale 21 score) after 6 weeks of pulmonary rehabilitation program as measured in our study.

conclusionPulmonary rehabilitation is feasible and appears promising in coronavirus disease acute respiratory distress syndrome survivors. However, data from other centers and a larger number of patients are required to imbibe conclusive results.

Identifiers

PMID35404239
PMCPMC9449983
OpenAlexW4220943169

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.